# Evaluation of Solifenacin in the Treatment of OAB Symptoms in Patients Who Have Successfully Undergone GreenLight Photoselective Vaporization of the Prostate (PVP)

> **NCT00826527** · PHASE4 · UNKNOWN · sponsor: **Seattle Urology Research Center** · enrollment: 23 (estimated)

## Conditions studied

- Urinary Frequency
- Urinary Urgency
- Nocturia

## Interventions

- **DRUG:** Solifenacin PO

## Key facts

- **NCT ID:** NCT00826527
- **Lead sponsor:** Seattle Urology Research Center
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2007-01
- **Primary completion:** 2009-12
- **Final completion:** —
- **Target enrollment:** 23 (ESTIMATED)
- **Last updated:** 2009-01-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00826527

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00826527, "Evaluation of Solifenacin in the Treatment of OAB Symptoms in Patients Who Have Successfully Undergone GreenLight Photoselective Vaporization of the Prostate (PVP)". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT00826527. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*